Cargando…

Participant-centred active surveillance of adverse events following immunisation: a narrative review

The importance of active, participant-centred monitoring of adverse events following immunisation (AEFI) is increasingly recognised as a valuable adjunct to traditional passive AEFI surveillance. The databases OVID Medline and OVID Embase were searched to identify all published articles referring to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cashman, Patrick, Macartney, Kristine, Khandaker, Gulam, King, Catherine, Gold, Michael, Durrheim, David N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881255/ https://www.ncbi.nlm.nih.gov/pubmed/28582563 http://dx.doi.org/10.1093/inthealth/ihx019

Ejemplares similares

Participant-Centered Online Active Surveillance for Adverse Events Following Vaccination in a Large Clinical Trial: Feasibility and Usability Study
por: Munnoch, Sally-Anne, et al.
Publicado: (2019)

Active surveillance study of adverse events following immunisation of children in the Czech Republic
por: Danova, Jana, et al.
Publicado: (2017)

Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance
por: Phillips, Anastasia, et al.
Publicado: (2021)

Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia
por: Wood, Nicholas, et al.
Publicado: (2023)

Healthcare providers’ knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study
por: Parrella, Adriana, et al.
Publicado: (2013)

Adverse events following primary and secondary immunisation with whole-cell pertussis: a systematic review protocol
por: Patterson, Jenna, et al.
Publicado: (2017)

Immunisation provider experiences with an automated short message service-based active surveillance system for monitoring adverse events following immunisation: A qualitative descriptive study
por: Singh, Gurkamal, et al.
Publicado: (2021)

The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada
por: Bettinger, Julie A, et al.
Publicado: (2022)

Closing the gap in Australian Aboriginal infant immunisation rates -- the development and review of a pre-call strategy
por: Cashman, Patrick M., et al.
Publicado: (2016)

Adverse events following COVID-19 immunisation (AEFI) at a COVID-19 vaccination centre: An observational analytical study
por: Shukla, Vinita, et al.
Publicado: (2023)

Frequency of Adverse Events Following Q Fever Immunisation in Young Adults
por: Sellens, Emily, et al.
Publicado: (2018)

Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016
por: Mentzer, Dirk, et al.
Publicado: (2018)

Adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
por: Marfoh, Kissinger, et al.
Publicado: (2023)

Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia
por: Pillsbury, Alexis J, et al.
Publicado: (2018)

A Discrete-Event, Simulated Social Agent-Based Network Transmission (DESSABNeT) model for communicable diseases: Method and validation using SARS-CoV-2 data in three large Australian cities
por: Stapelberg, Nicolas J. C., et al.
Publicado: (2021)

Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study
por: Jacoby, Peter, et al.
Publicado: (2020)

Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017
por: Masuka, Josiah Tatenda, et al.
Publicado: (2019)

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

Adverse events following immunisation with the first dose of sputnik V among Iranian health care providers
por: Jafarzadeh Esfehani, Reza, et al.
Publicado: (2023)

Correction to: Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

Optimising reporting of adverse events following immunisation by healthcare workers in Ghana: A qualitative study in four regions
por: Aborigo, Raymond Akawire, et al.
Publicado: (2022)

mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation
por: Fenton, Caroline, et al.
Publicado: (2022)

The short term safety of COVID‐19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021
por: Deng, Lucy, et al.
Publicado: (2022)

POS-903 ADVERSE EVENTS FOLLOWING IMMUNISATION (AEFI) OF COVID-19 VACCINES IN KIDNEY PATIENTS- A CASE SERIES
por: KIG TSUEW, Y., et al.
Publicado: (2022)

Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria
por: Shragai, Talya, et al.
Publicado: (2023)

Influenza surveillance and immunisation in New Zealand, 1997–2006
por: Sue Huang, Q., et al.
Publicado: (2008)

Assessing the impact of polio supplementary immunisation activities on routine immunisation and health systems: a systematic review
por: Vassallo, Amy, et al.
Publicado: (2021)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023)

Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines
por: Pillsbury, Alexis, et al.
Publicado: (2023)

Structural and social inequities contribute to pockets of low childhood immunisation in New South Wales, Australia
por: Thomas, Susan, et al.
Publicado: (2022)

Antidepressants and cardiovascular adverse events: A narrative review
por: Nezafati, Mohammad Hassan, et al.
Publicado: (2015)

Analysis of serious adverse event: Writing a narrative
por: Nambiar, Indu
Publicado: (2018)

Characteristics of immunisation support programmes in Canada: a scoping review and environmental scan
por: Kelly, Katherine Jennifer, et al.
Publicado: (2023)

Surveillance of serious adverse events following immunization in resource poor settings
por: Breugelmans, Gabrielle J, et al.
Publicado: (2011)

Use of electronic immunization registry in the surveillance of adverse events following immunization
por: Sato, Ana Paula Sayuri, et al.
Publicado: (2018)

Evaluation of the adverse events following immunization surveillance system, Ghana, 2019
por: Laryea, Eunice Baiden, et al.
Publicado: (2022)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
por: Pan, Xuejiao, et al.
Publicado: (2022)

Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review
por: Bhandari, Bijay, et al.
Publicado: (2022)

Communicating with patients and the public about COVID‐19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation
por: Leask, Julie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9m2t52tb31v1tiqtc760giudg